About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Thursday, March 3rd, 2016

The QualityStocks
Daily Stock List


Innovus Pharmaceuticals, Inc. (INNV)

PennyPickAlerts, Fortune Stock Alerts, BUYINS.NET, Penny Stock Bets, StockMister, Penny Stock Circle, StockMarketQuote.us, 1-2-3 Stock Alerts, and OTPicks reported on Innovus Pharmaceuticals, Inc. (INNV), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Innovus Pharmaceuticals, Inc. is a developing pharmaceuticals company with its corporate headquarters in San Diego, California. Innovus focuses on the commercialization of over-the-counter (OTC) and consumer products for men's and women's health, vitality and respiratory diseases.  It markets its products in the United States and Canada through retailers and on the web. In addition, it details its products to urologists, gynecologists and sex therapists. The Company does so either directly in the United States or through commercial partners around the world. Innovus Pharmaceuticals lists on the OTC Markets’ OTCQB.

At present, the Company’s product family consists of Zestra® (for female arousal, desire and satisfaction), EjectDelay™ (for premature ejaculation), Sensum+™ (for reduced penile sensitivity - for sales outside the U.S. only), Zestra Glide® (a high viscosity low molarity female water based lubricant) and Vesele®.

Vesele® is a proprietary, novel, and safer oral dietary supplement to maximize nitric oxide's beneficial effects on sexual function and brain health. Vesele® contains a patented formulation of L-Arginine and L-Citrulline, in combination with the natural absorption enhancer Bioperine®.

Innovus Pharmaceuticals has in-licensed the product Androferti® (in the U.S. and Canada) to support overall male reproductive health and sperm quality. Moreover, it has added a number of large online retailers for its products.

In addition, the Company acquired FlutiCare™ (Fluticasone Propionate Nasal Spray for Allergic Rhinitis). It expects to launch this product this year, subject to the U.S. Food and Drug Administration's (FDA’s) approval of the abbreviated new drug application for the OTC version.

Innovus Pharmaceuticals has signed numerous commercial partners for its EjectDelay® product in many countries. This includes Orimed in Canada; Ovation Pharma in Morocco; Tabuk Pharma in the MENA region; Elis Pharma in Turkey and select other countries; and Oz Biogenics in Myanmar and Vietnam.

This week, Innovus Pharmaceuticals announced the closing of the acquisition for substantially all of the assets of Beyond Human, for a cash purchase price of $630,000. Beyond Human is best known for its natural Testosterone Booster supplement, Beyond T Human®, and its natural Human Growth Agent HGA®, among other products.

Dr. Bassam Damaj, President and CEO of Innovus Pharmaceuticals, said, "The closing of the acquisition of the Beyond Human assets marks a turning point in Innovus Pharma revenue scale-up and we believe it should help the Company move into a cash flow positive situation followed by profitability very quickly."

Innovus Pharmaceuticals, Inc. (INNV), closed Thursday's trading session at $0.055, up 10.00%, on 178,800 volume with 12 trades. The average volume for the last 60 days is 94,761 and the stock's 52-week low/high is $0.028/$0.235.

Oculus VisionTech, Inc. (OVTZ)

Profit Status and UltimatePennyStock reported previously on Oculus VisionTech, Inc. (OVTZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Oculus VisionTech, Inc. designs and markets (to business customers) streaming video content distribution, and Internet Cloud-based digital document protection, based on embedded digital watermarking, and also video-on-demand (VOD) systems, services and source-to-destination digital media delivery solutions, which permit live or recorded digitized and compressed video to be transmitted via Internet, intranet, satellite or wireless connectivity. Listed on the OTCQB, Oculus VisionTech has its corporate headquarters in Vancouver, British Columbia.

The Company's systems, services and delivery solutions include document, still image and motion video digital watermark solutions and documents, photographs (still image) and video content protection. Its technology includes SmartMarks™ and Cloud-DPS.

SmartMarks™ are invisible, unremovable, and imperceptible forensic "digital watermarks". These are embedded within every video frame to protect digital video from piracy.

The Company’s Document Watermarking Protection technology will be provided as a Cloud service – Cloud DPS. Cloud DPS provides three document services from the Cloud. One is Protection - accept any incoming document, watermark and return the watermarked document as an encrypted image-based PDF document. The second is Authenticate - validate the authenticity of the protected documents. The third is Storage - storage of the master protected document in a digital.

Oculus VisionTech’s products include MediaEscort™. This product takes un-watermarked original video content, watermarks the content, and transforms the content into DRM encoded protected content. The Company also has its MediaEscort™ Streaming Edition (MESE). MESE embeds visually imperceptible unique watermarks within (every single frame of) online real time videos, which are usually deployed in cloud computing environments.

Recently, Oculus VisionTech announced the successful completion of Alpha testing of its Cloud-based Document Protection System (Cloud-DPS) and the start of field trials. The field stage of product testing will center on the Cloud-DPS's document protection features. It will involve nationwide testing in the U.S. by a selected technology partner of Oculus VisionTech.

Furthermore, Oculus VisionTech announced that, subsequent to the successful completion of alpha testing of its Cloud-based Document Protection System (DPS) technology and the beginning of field trials of the document protection features of its Cloud-DPS technology, it is in the process of implementing its proprietary watermarking technology to its new photo DPS product, which will provide online, Cloud-based security for documents in general, and which can be optimized for digital photographs in particular, and which is invariant to document/photo file format  - and then to today's image/video CODECs.

Oculus VisionTech, Inc. (OVTZ), closed Thursday's trading session at $0.45, even for the day, on 16,700 volume with 23 trades. The average volume for the last 60 days is 19,767 and the stock's 52-week low/high is $0.065/$0.7966.

American Power Group Corp. (APGI)

Marketbeat.com and SmallCapVoice reported earlier on American Power Group Corp. (APGI), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

American Power Group Corp. designs and produces proven alternative fuel solutions for stationary power generators, backup power systems, and commercial transportation. Its alternative energy subsidiary, American Power Group, Inc. (APG), provides a cost-effective patented Turbocharged Natural Gas™ conversion technology for vehicular, stationary, and off-road mobile diesel engines. American Power Group is headquartered in Lynnfield, Massachusetts.

The Company’s dual fuel technology is a pioneering non-invasive energy enhancement system. The dual fuel technology system converts existing diesel engines into more efficient and environmentally friendly engines. These engines have the flexibility to run on diesel fuel and liquefied natural gas (LNG); diesel fuel and compressed natural gas; diesel fuel and pipeline or well-head gas; and diesel fuel and bio-methane. These engines have the flexibility to return to 100 percent diesel fuel operation at any time.

Pertaining to American Power Group’s dual fuel, methane gas is metered into a diesel engine's air intake, before the turbocharger, by the air filter. As the enriched air/gas mixture increases the engine's power, the diesel's own governor senses the power increase and backs off on diesel flow. The system maintains a balance of gas-to-diesel ratios, approximately 80-50 percent natural gas to 20-50 percent diesel fuel, keeping the proper British Thermal Unit (BTU) energy within the engine across its power curve.

The maintaining of the energized fuel balance is with a proprietary read-only electronic controller system. This ensures the engines operate at original equipment manufacturers' (OEMs) specified temperatures and pressures. Installation on a broad spectrum of engine models and end-market applications necessitates no engine modifications.

With its proprietary Flare to Fuel™ process technology, the Company can convert captured gases into natural gas liquids (NGL), which can sell as heating fluids, emulsifiers, or be further processed by refiners. By way of American Power Group’s Trident Associated Gas Capture and Recovery Technology, it can provide oil and gas producers a flare capture service solution for associated gases produced at their remote and stranded well sites.

Last month, American Power Group announced that its subsidiary, American Power Group, Inc. (APG) received follow on purchase orders from two of its top United States customers for APG V5000 Turbocharged Natural Gas® Systems and supporting CNG fueling systems. These new orders total more than $600,000. The expectation is that these orders will ship during the current quarter and into American Power Group’s third fiscal quarter and will bring the two customers' collective APG dual fuel truck fleet to more than one hundred units.

American Power Group Corp. (APGI), closed Thursday's trading session at $0.14, up 15.46%, on 90,299 volume with 25 trades. The average volume for the last 60 days is 60,505 and the stock's 52-week low/high is $0.08/$0.49.

OncBioMune Pharmaceuticals, Inc. (OBMP)

Journal Transcript and MissionIR reported recently on OncBioMune Pharmaceuticals, Inc. (OBMP), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

OncBioMune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company headquartered in Baton Rouge, Louisiana. The Company engages in the development of novel cancer products and a proprietary vaccine technology. It has a proprietary Vaccine Technology designed to stimulate the immune system to attack its own cancer while not hurting the patient. OncBioMune Pharmaceuticals incorporates scientifically proven and clinically validated treatments for cancer. The Company’s shares trade on the OTCQB.

The Company’s lead product is ProscaVax™ - OncBioMune’s novel cancer vaccine for prostate cancer. It is scheduled to begin a Phase 2 clinical study this year. In addition, OncBioMune has a portfolio of targeted therapies. Some of these are biosimilars to blockbuster drugs.

OncBioMune has developed the therapeutic cancer vaccine for prostate cancer patients using similar techniques developed for breast cancer patients. The Company states that it is tested and laboratory proven and that it could become the standard of care for prostate cancer treatment. The Company uses patented technology developed and or acquired by OncBioMune.

Dr. Jonathan Head, Ph.D. is the Chief Executive Officer and Chairman of OncBioMune Pharmaceuticals. He has been instrumental in the development of the Company’s new chemotherapy and immunotherapy programs.

Last month, OncBioMune Pharmaceuticals reported positive results from its Phase 1 clinical trial of ProscaVax™. The trial is hosted at the University of California San Diego Moores Cancer Center and the Veterans' Hospital, La Jolla, California, to evaluate the safety and efficacy of ProscaVax™ in patients with recurrent disease. This is defined as rising Prostate-Specific Antigen (PSA) after initial treatment (surgery, radiation, or brachytherapy/radioactive seeds).

Dr. Jonathan Head commented, “The Phase 1a study has provided us with what we need to move into a Phase 2 clinical trial of ProscaVax by further validating the safety of ProscaVax and signs of efficacy with respect to increase immune responses to PSA. This points us squarely at focusing on early stage prostate cancer patients, which happens to be the largest market and an area of significant unmet medical need."

OncBioMune Pharmaceuticals, Inc. (OBMP), closed Thursday's trading session at $1.06, down 3.64%, on 5,800 volume with 17 trades. The average volume for the last 60 days is 2,059 and the stock's 52-week low/high is $0.45/$8.50.

Simba Energy, Inc. (SMBZF)

PhD-Trading and SmallCapVoice reported previously on Simba Energy, Inc. (SMBZF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Simba Energy, Inc. is an oil and gas exploration junior. Its emphasis is on the onshore frontier basins of Africa. Simba acquires, explores, and develops oil and gas properties in Africa. The Company was previously known as Gold Star Resources Corp. It changed its name to Simba Energy, Inc. in February of 2010. The Company lists on the OTC Markets Group’s OTCQB. Simba Energy has its headquarters in Vancouver, British Columbia.

The Company’s corporate mission is to concentrate on onshore oil and gas potential in areas that are under-developed or not previously exploited. Simba Energy’s portfolio consists of onshore Production Sharing Contracts (PSCs) in Chad, Kenya and Guinea. Simba Energy’s onshore PSCs in Ghana and Liberia are presently undergoing ratification. Simba will look for farm-in partners (as potential is identified) to heighten and progress the exploration of assets before beginning on exploration drilling.

The Company’s main strengths include a diversified onshore portfolio consisting of high impact early stage oil & gas assets in Africa, as well as majority interests and control of assets. Simba’s strengths also include excellent relations with host governments as well as the above-mentioned large onshore acreage positions in African frontier basins. Simba maintains a strong, local, on the ground presence in its priority nations to optimize progress.

  In January of this year, Simba Energy announced that it closed its earlier announced (November 2, 2015) non-brokered private placement to raise gross proceeds of $2,100,749.00. Simba issued 42,014,975 units at a price of $0.05 per Unit, each Unit comprising one share and one-half of one warrant, with each whole warrant entitling the holder to purchase one Warrant Share at an exercise price of $0.075 per Warrant Share for a period of two years. Simba Energy’s plan is to use the proceeds of the Private Placement to fund exploration commitments associated with its PSCs in Kenya, and general working capital purposes.

Simba Energy, Inc. (SMBZF), closed Thursday's trading session at $0.0384, up 15.66%, on 40,000 volume with 6 trades. The average volume for the last 60 days is 18,530 and the stock's 52-week low/high is $0.0072/$0.0725.


The QualityStocks
Company Corner


Immune Therapeutics, Inc. (IMUN)

The QualityStocks Daily Newsletter would like to spotlight Immune Therapeutics, Inc. (IMUN). Today, Immune Therapeutics, Inc. closed trading at $0.165, off by 0.54%, on 45,091 volume with 10 trades. The stock’s average daily volume over the past 60 days is 145,168, and its 52-week low/high is $0.36/$0.045.

Immune Therapeutics, Inc. today announced the appointment of two new members to its Board of Directors: Clifford A. Selsky, Ph.D., MD, and Paul Akin. "Paul Akin and Dr. Selsky 's breadth of knowledge and experience will provide invaluable insight to Immune as we continue to grow the business and strive to deliver innovative therapies in emerging nations," said Noreen Griffin, CEO. "I'm pleased to welcome both Paul Akin and Dr. Clifford Selsky to the board. Paul brings an extraordinary depth of financial experience developed across his operating and board roles, while Dr. Selsky brings critical perspective as a scientist, physician and patient advocate," said Chris Pearce COO.

Immune Therapeutics, Inc. (IMUN) is a biotechnology company applying its patented immunotherapy to combat chronic, life-threatening diseases that affect persons around the world. Building on the power of the body's natural immune system, the company's pipeline of products and immunotherapy technologies are designed to enhance treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and a variety of autoimmune diseases.

Immune Therapeutics' most advanced clinical programs involve immunotherapy with met-enkephalin (MENK) (sometimes referred to as opioid growth factor) and its low dose naltrexone product (LDN), internationally known as Lodonal™, both of which have been shown to stimulate immune systems even in patients with advanced cancer.

Additionally, Immune Therapeutics is pursuing additional investigations for MENK and LDN as viable treatments for autoimmune conditions such as rheumatoid arthritis and multiple sclerosis; as an adjunct in cancer patients undergoing chemotherapy, radiation treatments or surgery; and as a complement to antibiotics in the treatment of a variety of infectious diseases, including patients with HIV/AIDS, in combination with retroviral drug therapy.

Immune Therapeutics and partners AHAR Pharma and GB Pharma Holdings recently completed a bridging trial to determine the safety and efficacy of LDN in patients with HIV, and have submitted data in connection with the filing of its New Drug Application for LDN with The National Agency for Food and Drug Administration and Control, (NAFDAC) of Nigeria. Disclaimer

Immune Therapeutics, Inc. Company Blog

Immune Therapeutics, Inc. News:

Immune Therapeutics, Inc., Appoints Two New Board Members

Immune Therapeutics, Inc to Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

SeeThruEquity Initiates Coverage on Immune Therapeutics, Inc. with a Price Target of $0.61

Alternet Systems, Inc. (ALYI)

The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.01395, up 74.37%, on 88,000 volume with 6 trades. The stock’s average daily volume over the past 60 days is 59,149, and its 52-week low/high is $0.0055/$0.045.

Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.

Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets

Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.

Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.

With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.

As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer

Alternet Systems, Inc. Company Blog

Alternet Systems, Inc. News:

Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation

Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base

Alternet Systems (ALYI) CEO Featured in Exclusive QualityStocks Interview

Giggles N' Hugs, Inc. (GIGL)

The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.0899, up 45.00%, on 400 volume with 1 trade. The stock’s average daily volume over the past 60 days is 44,284, and its 52-week low/high is $0.0137/$0.32.

Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.

In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.

Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.

Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.

Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer

Giggles N' Hugs, Inc. Company Blog

Giggles N' Hugs, Inc. News:

Giggles N' Hugs, Inc. (GIGL) CEO Discusses 2016 Growth Strategies in Second QualityStocks Interview

Giggles Ní Hugs Signs Agreement with New York-Based Chardan Capital Markets

Giggles N Hugs to present at the 8th annual LD Micro Conference main event

View Systems, Inc. (VSYM)

The QualityStocks Daily Newsletter would like to spotlight View Systems, Inc. (VSYM). Today, View Systems, Inc. closed trading at $0.0016, up 6.67%, on 473,020 volume with 5 trades. The stock’s average daily volume over the past 60 days is 598,336, and its 52-week low/high is $0.0011/$0.015.

View Systems, Inc. (VSYM) is a leading security technology products company with “state-of-the-art” technological solutions for modern security problems. Targeting the challenging business opportunities in the opening decades of the 21st century and beyond, View Systems has solutions for law enforcement facilities such as correctional institutions as well as other government agencies, schools, courthouses, event and sports venues, the military and commercial businesses.

The senior management team is comprised of successful businessmen with decades of business and professional experience in the security industry. The approach used by View Systems utilizes the expertise of this team to provide innovative solutions to security problems with reliable “cutting edge” products in conjunction with client-oriented security consulting services.

The company’s flagship product, ViewScan, is an advanced walk-through Concealed Weapons Detection System (CWD) that greatly simplifies the process of discriminating suspicious items from harmless ones. The highly sensitive, completely passive sensor technology powering the system accurately detects the location and number of threat objects such as knives, guns and razor blades while ignoring personal artifacts like coins, keys and belt buckles. A portable version of this system has only a fifteen minute setup time using only a screwdriver and it easily fits inside a golf size case.

Experts say the security industry has been the fastest-growing sector of the global economy during the past decade. Today, it is conservatively estimated to be a $100 billion-a-year industry and growing. As the business environment continues to get more complex, especially in foreign markets, View Systems is strategically positioned to capitalize on unsurpassed opportunity. Disclaimer

View Systems, Inc. Company Blog

View Systems, Inc. News:

View Systems, Inc. (VSYM) to Acquire Y.M. Advantage, Inc.

View Systems in Discussions With Three M&A Candidates and Reviewing Letter of Intent

View Systems, Inc. Files for Patent, Begins Manufacturing of Enhanced ViewScan Product

Agora Holdings, Inc. (AGHI)

The QualityStocks Daily Newsletter would like to spotlight Agora Holdings, Inc. (AGHI). Today, Agora Holdings, Inc. closed trading at $0.4175, up 5.67%, on 477,596 volume with 290 trades. The stock’s average daily volume over the past 60 days is 196,092, and its 52-week low/high is $0.03/$2.50.

Agora Holdings, Inc. (AGHI), together with its wholly-owned subsidiary, Geegle Media, is leading a diversified family entertainment and media enterprise through business segments which include: TV on Demand, interactive media, business products and consumer platforms. With its multi-dimensional approach, Geegle Media supports Agora Holdings' mission to deliver innovate and high-quality business solution products and to deliver video content from around the world.

Geegle Media web platforms include; GeegleTV, Frame, 1000Salads, RealtyTV and LobbyTV. Geegle TV is a multi-platform video entertainment website that curates high-quality video content from around the world. In 2016, GeegleTV will serve as co-producer by airing original content. By exposing undiscovered content to millions of users and rendering it shareable to social media, Geegle TV will serve as a marketing partner to local and internationally based TV shows not yet on the open market.

For commercial use, Geegle Media provides a variety of solutions that include web development and billing software for VoIP applications. RealtyTV is its state-of-the-art platform for real estate brokerages. LobbyTV is another of its widely used products by business offices. For individuals, Geegle TV combines radio, On Demand movies, news, sports and children's content.

Geegle Media is also developing 1000salads, an online hub that encourages healthy lifestyles. The portal will feature recipes and products, health-oriented articles and a curated selection of local restaurants and grocers that deliver to the health-conscious user. Currently in its alpha stage of development, 1000salads is gearing up its sales and marketing in preparation for its launch in 2016.

Geegle Media differs from other On Demand providers, such as Netflix and HBO, in that its service is free of constraints such as subscription, fees and penalties. As consumers increasingly opt for personalized sources of entertainment, Agora recognizes the vast opportunities and growth potential provided by the rising popularity of TV On Demand. The company also benefits from strong and visionary management with a track record of bringing innovative ideas to fruition. Disclaimer

Agora Holdings, Inc. Company Blog

Agora Holdings, Inc. News:

Agora Holdings Inc.'s Geegle Media Unveils Optimized FRAME for Business Use

Agora Holdings, Inc., (OTCMKTS: AGHI) Analyst Coverage; Preparation for the Launch of FRAME

Agora Holdings Inc.'s Geegle Media Set to Release FRAME This Month


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Top Stock Picks




The Street

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251